共 50 条
- [31] Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study Drug Safety, 2019, 42 : 1013 - 1024
- [34] Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study FRONTIERS IN NEUROLOGY, 2024, 15
- [37] Long-term persistence and compliance with darifenacin treatment for overactive bladder: results of a 2-year open-label extension study. PHARMACOTHERAPY, 2005, 25 (10): : 1493 - 1493
- [38] LONG-TERM EFFICACY AND SAFETY OF URO-902 (PVAX/HSLO) IN WOMEN WITH OVERACTIVE BLADDER AND URGE URINARY INCONTINENCE: FINAL RESULTS OF A PHASE 2A TRIAL JOURNAL OF UROLOGY, 2023, 209 : E1184 - E1184
- [40] EARLY ONSET AND CONSISTENT RESPONSE OF ONABOTULINUMTOXINA TREATMENT WITH SIGNIFICANT RESOLUTION OF URINARY SYMPTOMS IN FEMALE OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 : S19 - S20